Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2012-10-17

Clinical Trial Update: Catheter Ablation for Atrial Fibrillation and Heart Failure

View source ↗

Summary

The trial investigating catheter ablation for atrial fibrillation in patients with heart failure has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: St. Luke's-Roosevelt Hospital Center | Conditions: Congestive Heart Failure, Atrial Fibrillation | Status: WITHDRAWN